The "Weisbrod Quadrilemma" Revisited: Insurance Incentives on New Health Technologies

Article English OPEN
Costa-Font, J. ; McGuire, A. ; Serra-Sastre, V. (2012)
  • Publisher: Palgrave Macmillan
  • Journal: The Geneva Papers on Risk and Insurance Issues and Practice (vol: 37, pp: 678-695)
  • Related identifiers: doi: 10.1057/gpp.2012.37
  • Subject: HG | RA

The effect of insurance expansion on the diffusion of new technologies is not a well-understood phenomenon. Arguably, an expansion of insurance coverage provides a motivation for R&D investment in medical technologies. Although risk pooling through insurance gives rise to greater affordability for existing treatments and becomes a volume driver of new treatments, it may also influence provider reimbursement through a monopsony purchaser effect and related cost control measures. However the impact that insurance has on technology availability and R&D investment, and more generally on the adoption of new technologies remains an unexplored empirical question. This paper presents evidence of a link between insurance and technology diffusion using OECD panel data and taking advantage of a dynamic specification structure. Our empirical estimates indicate that higher degrees of private expenditure on health care correlate with higher levels of R&D in health care, consistent with the hypothesis forwarded by Weisbrod that increasing insurance coverage gives boosts technology adoption. However our findings also suggest that increasing public funding of health care appears to lower technological adoption, which is, of course, consistent with the exercising of monopsony power and an objective of cost containment.
  • References (24)
    24 references, page 1 of 3

    Berndt, E.R., Bir,A., Busch, S.H., Frank, R.G. and Normand, S.L.T. (2002) The Medical Treatment Of Depression, 1991-1996: Productive Inefficiency, Expected Outcome Variations, And Price Indexes, Journal of Health Economics, 2002, v21(3,May), 373-396.

    Breitung, J. and Pesaran, M.H. (2005) Unit roots and cointegration in panels. Deutsche Bundesbank Discussion paper, No. 42/2005.

    Comin, D., and Hobjn, B. (2010) An exploration of technology diffusion, American Economic Review, 100, 2031-2059.

    Cutler, D. (2004) Your Money or Your Life: Strong Medicine for America's Health Care System. New York, Oxford University Press.

    Cutler,D., McClelan, M., Newhouse, J., Remler, D. (1998) Are medical prices declining? Evidence from heart attack treatments, Quarterly Journal of Economics, 113, 901-1024Cutler and McClellan 2001, Is technical change in medicine worth it? Health Affairs, 20, 11-29.

    Cutler , D. M. and Huckman, R. S. (2003) Technological development and medical productivity: the diffusion of angioplasty in New York state. Journal of Health Economics, 22, 187-217.

    Eggleston, K., Shah, N.D., Smith, S.A., Berndt, E.R., and Newhouse, J.P. (2011) Quality adjustment for health care spending on chronic diseases: Evidence from diabetes treatment, 1999-2001, American Economic Review, 101, 206-211.

    Fuchs, V. (1984) Though Much is Taken : Reflections on Aging, Health and Medical Care, NBER Working Paper, No. 1269.

    Goddeeris, J., (1984), Insurance and Incentives for Innovation in Medical Care, Southern Economic Journal, Vol. 51, 530-539

    Im, K. S., Pesaran, M.H., and Shin, Y. (2003) Testing for unit roots in heterogeneous panels, Journal of Econometrics, 115, 53-74.

  • Metrics
    No metrics available
Share - Bookmark